Sign in

NCT05080010RecruitingPhase 3

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

Three Cycles of Adjuvant Chemotherapy for the Patients With High-risk Retinoblastoma After Enucleation: Prospective Study

Source: ClinicalTrials.gov · Last updated 15 Oct 2021 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
500 (estimated)
First submitted
2 Oct 2021
Start date
1 Nov 2020
Primary completion date
31 Dec 2030
Lead sponsor
Sun Yat-sen University
NCT number
NCT05080010

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 500
  • From 1 Nov 2020 to the primary completion date, 31 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous participation in any studies of investigational drugs within 1 month preceding Day 0 (excluding vitamins and minerals).

Other illness

  • Any previous disease in the study eye.
  • History of chemical intervention for retinoblastoma in the study eye.

Who the study is looking for

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study.
  • Definite pathology signs of retinoblastoma, Stage I base on International Retinoblastoma Staging System.
  • Received enucleation in the study eye.
  • Monocular retinoblastoma.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Zhongshan Ophthalmic Center,Sun Yat-Sen University
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.